Maureen Goodenow, PhD

Goodenow, Maureen 2017

Maureen M. Goodenow, Ph.D., is the NIH Associate Director for AIDS Research and Director of the NIH Office of AIDS Research (OAR). Dr. Goodenow has 30 years’ experience in HIV/AIDS research and advocacy. She joined NIH in July 2016 to lead OAR, working closely with the NIH institutes and centers to pursue new tools for preventing HIV infection including a vaccine, improved treatments, and ultimately, an end to the epidemic.

Prior to joining NIH, Dr. Goodenow was Professor of Pathology, Immunology, and Laboratory Medicine at the University of Florida College of Medicine, where she held the Stephany W. Holloway Endowed University Chair in HIV/AIDS Research.  She headed the Center for Research in Pediatric Immune Deficiency Diseases and led an HIV research program in HIV pathogenesis, genetic diversity, host/virus interactions at the molecular level, and the role of recreational marijuana in HIV-associated inflammation in youth living with HIV.  Dr. Goodenow has trained more than 50 next-generation scientists and published more than 100 articles.

Dr. Goodenow has also played an important role in international AIDS efforts as the Acting Director of the Office for Research and Science within the U.S. Department of State, Office of the U.S. Global AIDS Coordinator and Office of Global Health Diplomacy. There she oversaw combination prevention trials funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). From 2012-13, she also served as a senior science advisor and Jefferson Science Fellow in the Department of State, Bureau of East Asian and Pacific Affairs, Office of Economic Policy.

Dr. Goodenow has previously served on multiple NIH advisory committees, including the AIDS Research Advisory Committee for the Division of AIDS at the National Institute of Allergy and Infectious Diseases, and the OAR advisory committee for the Trans-NIH Plan for HIV-Related Research. She also advised a joint program between NIH and the U.S. Department of State to enhance research between U.S. and Russian scientists, and advised the Fogarty International Center on programs in India and Kazakhstan.